Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

A list of reasons why this is a SELL:

1) Starting a new research program before the last open trial hasn't released data yet! Classic move. Pump up the SP before dropping the bad news. Try to get excited about a phase 1 DMT study... it would be YEARS before ever getting to a phase 3, and most phase 1 flop... that's proven...
2) Execs paying themselves monster salaries with NO revenues.
3) Delays upon delays in delivering data...
4) Mark Williams working on another company... so is Kal!
5) Increasing the number of individuals in the preliminary trial results that flopped, in an effort to improve the statistical power to search for signal. I mean these guys literally included extra patients in the early data reading because they found nothing with fewer numbers... so FOR AMG/MONEY SHOT: THE SCIENCE FAILED
6)dilution upon dilution and Kal insider trading.
7) news releases every other day with no real material reporting just pumping

Someone please tell me why this should be a hold... all the signs point to this flopping on the next data release...

the promises WERE HIGH... PREVIOUSLY... but the prelim data wasn't good... such is life